Description
The Defense Health Agency (DHA) is planning to consolidate the contract requirements for clinical chemistry analyzers for twenty-four military treatment facilities (MTFs) within the DHA Contracting Activity (DHACA) Healthcare Contracting Division - West (HCD-W) area of responsibility. The consolidation will result in two to three single-award delivery orders utilizing the Department of Veterans Affairs (VA) Federal Supply Schedule (FSS) Group 66, Part III (66-III) contracts under category 605-1A for high maintenance/complexity clinical chemistry analyzers. The delivery orders will be consolidated based on MTF requirements for wet chemistry analyzers with automation, wet chemistry analyzers without automation, and dry chemistry analyzers. The consolidation is expected to provide substantial benefits to the Government, including cost savings, quality improvements, and reduction in acquisition cycle times.
• The consolidation will result in two to three single-award delivery orders.
• The delivery orders will be consolidated based on MTF requirements for wet chemistry analyzers with automation, wet chemistry analyzers without automation, and dry chemistry analyzers.
• The consolidation is expected to provide substantial benefits to the Government, including cost savings, quality improvements, and reduction in acquisition cycle times.
• The Government conducted extensive market research to determine the best strategy to meet mission requirements.
• The consolidation will utilize a "reagent rental" approach under a cost per reportable result (CPRR) pricing arrangement.